OPTI: Revenue up, losses down, and new funding to accelerate global commercialization

About this update from Opticept Technologies Ab

Q3 saw revenue growth, reduced losses, and major commercial agreements in food and plant tech. A SEK 80.4 million rights issue was announced to fund global expansion and commercialization, with strong open orders and a robust equity ratio.Original document: This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

View stock analysis, news, and events for Opticept Technologies Ab